South Korea’s capital is seeing a clear cooling of its housing market following the “6.27 loan regulation” (implemented end of June).

Dr. YoonHwa An is a physician, biotech strategist, and founder of BioPharma Business Intelligence Unit.

He brings 15+ years of experience across clinical affairs, BD, and risk diagnostics in the U.S., LATAM, and Korea.

His work integrates deep systems thinking with frontline operational insight.

“This site and its author are not affiliated with or endorsed by OpenAI.”